Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYTO

Altamira Therapeutics (CYTO) Stock Price, News & Analysis

Altamira Therapeutics logo

About Altamira Therapeutics Stock (NASDAQ:CYTO)

Advanced Chart

Key Stats

Today's Range
$0.30
$0.43
50-Day Range
$0.30
$0.52
52-Week Range
$0.30
$1.53
Volume
753,013 shs
Average Volume
310,905 shs
Market Capitalization
$1.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTO Stock News Headlines

Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Altamira Therapeutics Ltd. (CYTOF)
Altamira Therapeutics Ltd (CYTOF)
See More Headlines

CYTO Stock Analysis - Frequently Asked Questions

Shares of Altamira Therapeutics reverse split on the morning of Wednesday, December 13th 2023.The 1-20 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, December 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Altamira Therapeutics investors own include Plug Power (PLUG), Aridis Pharmaceuticals (ARDS), Soligenix (SNGX), Chemomab Therapeutics (CMMB), CNS Pharmaceuticals (CNSP), Cara Therapeutics (CARA) and Draganfly (DPRO).

Company Calendar

Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTO
CIK
1601936
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$320 thousand
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
0.07

Miscellaneous

Free Float
2,958,000
Market Cap
$1.02 million
Optionable
Not Optionable
Beta
1.80
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CYTO) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners